Filter results

Pharmaceutical Industry Reports

By Geography
By Sector
By Publication Type
Showing
1-20 of 113
Algeria Pharmaceuticals & Healthcare Report

Algeria Pharmaceuticals & Healthcare Report

BMI View: Algeria's pharmaceutical market will remain on a positive growth trajectory as the healthcare sector continues to develop over the coming years. Healthcare infrastructure modernisation and rising demand for chronic disease treatment will ...
$1,345.00
Read More
Angola Pharmaceuticals & Healthcare Report

Angola Pharmaceuticals & Healthcare Report

BMI View: Angola's weak intellectual property protection environment and its reliance on foreign donors to meet medicine demands make it one of the least attractive pharmaceutical markets in the region. A series of steep ...
$1,345.00
Read More
Argentina Pharmaceuticals & Healthcare Report

Argentina Pharmaceuticals & Healthcare Report

BMI View: Argentina will present significant opportunities to multinational drugmakers over the next 10 years although short-term challenges owing to high inflation and drug price freezes will keep a lid on consumption and weigh on revenue ...
$1,345.00
Read More
Asia Pharmaceuticals & Healthcare Report

Asia Pharmaceuticals & Healthcare Report

BMI View : Multinational pharmaceutical firms will continue to face the threat of medicine price controls in Asia. Pressures in favour of such measures will grow as governments seek to balance the need to sustain their ...
$1,345.00
Read More
Australia Pharmaceuticals & Healthcare Report

Australia Pharmaceuticals & Healthcare Report

BMI View: Reforms to Australia's drug approval process will be beneficial for both the pharmaceutical industry and for patient access to innovative medicines. In particular, the introduction of an expedited approval process will have ...
$1,345.00
Read More
Austria Pharmaceuticals & Healthcare Report

Austria Pharmaceuticals & Healthcare Report

BMI View: The Austrian healthcare system is highly regarded for its ability to deliver good quality services and its access to all citizens . On a per capita basis , however , it is one of the costliest ...
$1,345.00
Read More
Bahrain Pharmaceuticals & Healthcare Report

Bahrain Pharmaceuticals & Healthcare Report

BMI View: Bahrain, as well as the wider Gulf Cooperation Council (GCC) region, offers significant growth opportunities for pharmaceutical manufacturers, especially generic drugmakers. Sales of generic medicine will be driven by cost containment measures, growing ...
$1,345.00
Read More
Bangladesh Pharmaceuticals & Healthcare Report

Bangladesh Pharmaceuticals & Healthcare Report

BMI View: Bangladesh's long-term potential will be the central factor shaping its attractiveness to multinational drugmakers. Rising household incomes - coupled with improving healthcare access, driven largely by the influx of private hospitals into ...
$1,345.00
Read More
Belarus Pharmaceuticals & Healthcare Report

Belarus Pharmaceuticals & Healthcare Report

BMI View: Multinational pharmaceutical firms will be faced with numerous challenges despite Belarus exiting economic recession in 2017. B ias in the medicine tendering process, pricing controls and initiatives to boost the domestic drug-making industry will ...
$1,345.00
Read More
Belgium Pharmaceuticals & Healthcare Report

Belgium Pharmaceuticals & Healthcare Report

BMI View : Belgium offers a stable pharmaceutical market with high per capita spending on medicines. However, h eightened political uncertainty and a regional economic downturn will overshadow Belgium's economic outlook for the foreseeable future. ...
$1,345.00
Read More
Botswana Pharmaceuticals & Healthcare Report

Botswana Pharmaceuticals & Healthcare Report

BMI View: Botswana's pharmaceutical market will remain of little interest to multinational drugmakers. Despite a relatively attractive business environment, multinational drugmakers will continue to use South Africa as the main channel trough which medicines ...
$1,345.00
Read More
Brazil Pharmaceuticals & Healthcare Report

Brazil Pharmaceuticals & Healthcare Report

BMI View: The Brazilian pharmaceutical market will stimulate greater interest from foreign multinationals in the coming years. The weakening of the Brazilian real, government efforts to promote the local pharmaceutical industry and greater international collaboration ...
$1,345.00
Read More
Bulgaria Pharmaceuticals & Healthcare Report

Bulgaria Pharmaceuticals & Healthcare Report

BMI View: The long-term outlook for Bulgaria's pharmaceutical and healthcare markets is generally positive. The much-needed reforms to Bulgaria's healthcare system are facing continued opposition; however their implementation is set to improve patient ...
$1,345.00
Read More
Cambodia Pharmaceuticals & Healthcare Report

Cambodia Pharmaceuticals & Healthcare Report

BMI View: The combination of economic growth, rising disease awareness and gradual improvements in healthcare provision will underpin Cambodia's growing demand for medical treatment over a multi-year horizon. Albeit from a low base, the ...
$1,345.00
Read More
Cameroon Pharmaceuticals & Healthcare Report

Cameroon Pharmaceuticals & Healthcare Report

BMI View: Cameroon's recent ratification of the Economic Partnership Agreement (EPA) with the EU will support trade and economic growth over a multi-quarter horizon, with rising incomes set to benefit Cameroon's pharmaceutical and ...
$1,345.00
Read More
Canada Pharmaceuticals & Healthcare Report

Canada Pharmaceuticals & Healthcare Report

BMI View: Canada 's strong public ly funded health care system and stable political environment supply an attractive base for drug companies. We forecast steady market growth ; pricing and reimbursement pressures represent the main headwinds. ...
$1,345.00
Read More
Chile Pharmaceuticals & Healthcare Report

Chile Pharmaceuticals & Healthcare Report

BMI View: A stable political outlook and sound economic fundamentals position Chile's pharmaceutical market for steady growth. While obstacles such as the promotion of generic medicines and drug pricing pressures in both the public ...
$1,345.00
Read More
China Pharmaceuticals & Healthcare Report

China Pharmaceuticals & Healthcare Report

BMI View: Challenges facing multinational pharmaceutical firms in China will continue into 2017. Reflecting the ongoing evolution of the healthcare market, key trends in 2016 - such as the ban on public hospital drug mark-ups, pressure on ...
$1,345.00
Read More
Colombia Pharmaceuticals & Healthcare Report

Colombia Pharmaceuticals & Healthcare Report

BMI View: Multinational drugmakers will continue to face a tough business environment in Colombia. With a low oil price environment affecting government revenues, authorities will be incentivised to curb pharmaceutical expenditure as a means of ...
$1,345.00
Read More
Costa Rica Pharmaceuticals & Healthcare Report

Costa Rica Pharmaceuticals & Healthcare Report

BMI View: Costa Rica is, and will continue to be , one of the most attractive pharmaceutical market s in the Central America region . Although regulatory and patent enforcement concerns remain, steps are being taken to ...
$1,345.00
Read More
Showing
1-20 of 113